Bruce Keyt, Chief Scientific Officer at IGM Biosciences, Inc. (IGMS), sold 3,742 shares at $64.10 ($242K) on 2021-10-05, disclosed to the SEC on 2021-10-05.
Open-market sale of $242k IGMS by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.91 | 1,258 | $83K | 34.2% |
| 2 | $64.10 | 1,242 | $80K | 32.9% |
| 3 | $64.10 | 1,242 | $80K | 32.9% |
| Total | $64.71 avg | 3,742 | $242K | 100% |
| Filing → |
| IGMS | SELL | 2024-03-15 | $40K | — | Filing → |
| IGMS | SELL | 2023-12-15 | $44K | — | Filing → |
| IGMS | SELL | 2023-11-29 | $5K | — | Filing → |